1.
In Silico Insights into the Impact of Deleterious SNPs on the Functioning and Dynamics of TP53 and Its Targeted Therapy by COTI-2 and PRIMA1 in Breast Cancer Patients. UCP J. Sci. Technol. 2026;3(2):31-58. doi:10.24312/ucp-jst.03.02.523